Table 3.
TAFI and F 1 + 2 levels by gender, age, BMI and stage in the gastric cancer group
| TAFI Level | P-value | F 1 + 2 Level | P-value | ||
|---|---|---|---|---|---|
|
Gender |
Female |
63.6 ± 22.7 |
0.32 |
483.7 ± 230.8 |
0.28 |
| |
Male |
73.6 ± 39.1 |
|
598.3 ±379.2 |
|
|
Age |
>60 (n = 21) |
67.7 ± 32.1 |
0.52 |
614 ± 337.8 |
0.11 |
| |
≤60 (n = 12) |
73.5 ± 37.1 |
|
437.2 ± 280.5 |
|
|
BMI |
>25 (n = 15) |
65.7 ± 31.8 |
0.34 |
583.7 ± 328.7 |
0.47 |
| |
≤25 (n = 18) |
74.8 ± 34.8 |
|
521.3 ± 329.1 |
|
|
Stages |
Stage 1a (n = 1) |
93.3 |
0.92 |
484 |
0.81 |
|
Stage 1b (n = 0) |
- |
|
- |
|
|
|
Stage 2 (n = 5) |
68.2 ± 21.3 |
|
416.8 ± 80.9 |
||
|
Stage 3a (n = 14) |
69 ± 23. |
|
609.5 ± 354.7 |
|
|
|
Stage 3b (n = 4) |
71.8 ± 34 |
|
575 ± 498.7 |
|
|
| Stage 4 (n = 9) | 66.9 ± 51.9 | 526.6 ± 321 | |||